Company Filing History:
Years Active: 2004-2008
Title: Lucius Kemp: Innovator in Pain Management
Introduction
Lucius Kemp is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of pain management through his innovative research and development of pharmaceutical compounds. With a total of 4 patents to his name, Kemp has established himself as a key figure in the medical and pharmaceutical industries.
Latest Patents
Kemp's latest patents focus on N-type calcium channel antagonists for the treatment of pain. These compounds are designed to be effective in alleviating pain, as outlined in the structural diagrams provided in the specifications. The compounds are characterized by various groups defined in the specifications, along with pharmaceutical compositions and methods of treatment utilizing such compounds.
Career Highlights
Lucius Kemp is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address significant medical needs. His expertise in pharmacology and drug development has been instrumental in advancing pain management therapies.
Collaborations
Throughout his career, Kemp has collaborated with several esteemed colleagues, including Marc Chapdelaine and John McCauley. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic approaches.
Conclusion
Lucius Kemp's contributions to the field of pain management through his patents and work at AstraZeneca highlight his dedication to improving patient outcomes. His innovative spirit and collaborative efforts continue to drive advancements in pharmaceutical research.